# MM Resistance Prediction Mission - Comprehensive Audit Report

**Date:** January 28, 2025  
**Auditor:** Auto  
**Mission Document:** `.cursor/MOAT/MISSION_MM_RESISTANCE_PREDICTION.mdc`  
**Status:** ⚠️ **PARTIAL IMPLEMENTATION** - ~40% Complete

---

## 🎯 EXECUTIVE SUMMARY

The MM Resistance Prediction mission document outlines an ambitious 3-4 week plan to build production-ready resistance prediction for Multiple Myeloma. **Current reality: ~40% of the planned features are implemented**, with a working foundation but significant gaps in mechanism expansion, validation, and frontend integration.

### **Overall Status:**
```
Foundation (Backend API):     ████████████░░░░░░░░  60% ✅
Mechanism Expansion:          ████░░░░░░░░░░░░░░░░  20% ⚠️
Validation Framework:         ░░░░░░░░░░░░░░░░░░░░   0% ❌
Frontend Integration:        ████░░░░░░░░░░░░░░░░  20% ⚠️
Data Acquisition:            ░░░░░░░░░░░░░░░░░░░░   0% ❌
TRUE SAE Integration:         ░░░░░░░░░░░░░░░░░░░░   0% ❌

TOTAL:                       ████████░░░░░░░░░░░░  40% ⚠️
```

---

## ✅ WHAT EXISTS (Code-Validated)

### **1. Backend API Foundation** ✅ **60% COMPLETE**

#### **Files:**
- ✅ `oncology-coPilot/oncology-backend-minimal/api/routers/resistance.py` - **EXISTS**
  - Endpoint: `POST /api/resistance/predict`
  - Supports MM via `predict_mm_resistance()` method
  - Disease-agnostic architecture (MM + OV)
  - **Status:** Production-ready for basic MM resistance

- ✅ `oncology-coPilot/oncology-backend-minimal/api/services/resistance_prophet_service.py` - **EXISTS**
  - `predict_mm_resistance()` method implemented
  - MM-specific signals: `MM_HIGH_RISK_GENE`, `MM_CYTOGENETICS`
  - Treatment line adjustment logic
  - Cross-resistance detection
  - **Status:** Core prediction logic working

- ✅ `oncology-coPilot/oncology-backend-minimal/api/services/resistance_playbook_service.py` - **EXISTS**
  - `get_next_line_options()` for MM
  - Alternative drug recommendations
  - Regimen change suggestions
  - **Status:** Playbook integration working

#### **What Works:**
- ✅ MM resistance prediction endpoint (`/api/resistance/predict`)
- ✅ Gene-level markers: DIS3 (RR=2.08), TP53 (RR=1.90) - **VALIDATED**
- ✅ Cytogenetics support: del(17p), t(4;14), 1q gain - **LITERATURE-BASED**
- ✅ Treatment line context (1L, 2L, 3L+ multipliers)
- ✅ Cross-resistance detection (same-class prior therapy)
- ✅ Next-line drug recommendations via playbook service

#### **Limitations:**
- ⚠️ Only 2 validated genes (DIS3, TP53) - mission calls for 10+ genes
- ⚠️ No PSMB5/CRBN direct resistance mutations (mission priority)
- ⚠️ No pathway burden computation (mission Phase 2)
- ⚠️ No Evo2 integration (mission Phase 4)

---

### **2. MM High-Risk Gene Markers** ✅ **PARTIAL**

#### **Validated Markers (Proxy SAE - Gene-Level):**
```python
# From resistance_prophet_service.py lines 113-187
MM_HIGH_RISK_GENES = {
    "DIS3": {
        "relative_risk": 2.08,
        "p_value": 0.0145,
        "confidence": 0.95,
        "validation_source": "MMRF_CoMMpass_GDC",
        "n_mutated": 38,
        "mechanism": "RNA surveillance deficiency"
    },
    "TP53": {
        "relative_risk": 1.90,
        "p_value": 0.11,
        "confidence": 0.75,
        "validation_source": "MMRF_CoMMpass_GDC",
        "n_mutated": 16,
        "mechanism": "Genomic instability, therapy resistance"
    },
    # Literature-based (not validated):
    "NFE2L2": {...},  # Literature only
    "XBP1": {...},    # Literature only
    "IRE1": {...}     # Literature only
}
```

#### **Status:**
- ✅ DIS3 validated (RR=2.08, p=0.0145) - **SIGNIFICANT**
- ✅ TP53 validated (RR=1.90, p=0.11) - **TREND**
- ⚠️ NFE2L2, XBP1, IRE1 - Literature-based only (no validation)
- ❌ PSMB5, CRBN, IKZF1/3, CUL4A, DDB1 - **NOT IMPLEMENTED** (mission priority)

---

### **3. MM Cytogenetics** ✅ **LITERATURE-BASED**

#### **Cytogenetics Support:**
```python
# From resistance_prophet_service.py lines 189-236
MM_CYTOGENETICS = {
    "del_17p": {"hazard_ratio": 2.5, "interpretation": "ULTRA_HIGH_RISK"},
    "t_4_14": {"hazard_ratio": 1.8, "interpretation": "HIGH_RISK"},
    "1q_gain": {"hazard_ratio": 1.5, "interpretation": "HIGH_RISK"},
    "t_11_14": {"hazard_ratio": 0.8, "interpretation": "VENETOCLAX_SENSITIVE"}
}
```

#### **Status:**
- ✅ Cytogenetics detection implemented
- ⚠️ Literature-based only (MMRF has no cytogenetics data)
- ✅ Integrated into `predict_mm_resistance()` method
- ❌ No validation against MMRF cohort (mission Phase 3)

---

### **4. Frontend Components** ⚠️ **PARTIAL**

#### **Files:**
- ✅ `oncology-coPilot/oncology-frontend/src/pages/MyelomaDigitalTwin.jsx` - **EXISTS**
- ✅ `oncology-coPilot/oncology-frontend/src/components/myeloma/MyelomaResponseDisplay.jsx` - **EXISTS**
- ❌ `oncology-coPilot/oncology-frontend/src/components/myeloma/MMResistancePanel.jsx` - **NOT FOUND** (mission calls for this)

#### **Status:**
- ✅ Basic MM frontend exists
- ⚠️ No dedicated resistance prediction panel (mission Phase 4)
- ⚠️ Integration with resistance API unclear

---

## ❌ WHAT'S MISSING (Critical Gaps)

### **1. Expanded Resistance Mutations** ❌ **0% COMPLETE**

#### **Mission Requirement:**
The mission document (lines 1405-2806) calls for comprehensive MM resistance mutations:

```python
MM_RESISTANCE_MUTATIONS = {
    "proteasome_inhibitor": {
        "PSMB5": {...},  # p.Ala49Thr, p.Ala20Thr, etc.
        "PSMB8": {...},
        "NFE2L2": {...},
        "KEAP1": {...},
        "XBP1": {...},
        "IRE1": {...}
    },
    "imid": {
        "CRBN": {...},  # p.Trp400*, p.Arg419*, etc.
        "IKZF1": {...},
        "IKZF3": {...},
        "CUL4A": {...},
        "DDB1": {...}
    },
    "anti_cd38": {
        "CD38": {...},
        "CD55": {...},
        "CD59": {...}
    },
    "bcma_targeted": {
        "TNFRSF17": {...}
    }
}
```

#### **Current Reality:**
- ❌ **NOT IMPLEMENTED** - No `MM_RESISTANCE_MUTATIONS` dictionary
- ❌ PSMB5 mutations not checked (mission priority #1)
- ❌ CRBN mutations not checked (mission priority #2)
- ❌ Only DIS3/TP53 checked (gene-level, not drug-class specific)

#### **Impact:** 🔴 **CRITICAL**
- Cannot predict PI resistance from PSMB5 mutations
- Cannot predict IMiD resistance from CRBN mutations
- Missing core mission functionality

---

### **2. MM Pathway Service** ❌ **NOT CREATED**

#### **Mission Requirement:**
- File: `api/services/mm_pathway_service.py` (mission line 284-340)
- Function: `compute_mm_pathway_burden()`
- Pathways: proteasome_upr, cereblon_pathway, ras_mapk, nrf2_antioxidant, plasma_cell_survival, drug_efflux

#### **Current Reality:**
- ❌ File does not exist
- ❌ No pathway burden computation
- ❌ No MM-specific pathway mapping

#### **Impact:** 🟡 **HIGH**
- Cannot compute pathway-based resistance signals
- Missing mechanism-level prediction (mission Phase 2)

---

### **3. MM Resistance Service** ❌ **NOT CREATED**

#### **Mission Requirement:**
- File: `api/services/mm_resistance_service.py` (mission line 403-475)
- Class: `MMResistanceService`
- Method: `predict_resistance()` with full context (mutations, cytogenetics, treatment line, prior therapies)

#### **Current Reality:**
- ⚠️ Logic exists in `resistance_prophet_service.py` but not as dedicated service
- ❌ No dedicated `MMResistanceService` class
- ⚠️ Basic prediction works but lacks full mechanism integration

#### **Impact:** 🟡 **MEDIUM**
- Functionality exists but not organized as mission specifies
- Missing dedicated service layer

---

### **4. Validation Framework** ❌ **0% COMPLETE**

#### **Mission Requirement:**
- File: `scripts/validation/validate_mm_resistance.py` (mission line 344-387)
- Tests:
  1. PSMB5 → PI Resistance (RR ≥ 2.0)
  2. CRBN → IMiD Resistance (RR ≥ 2.5)
  3. del(17p) → Universal Resistance (HR ≥ 2.0)
  4. RAS/MAPK → Treatment Line Impact
  5. Evo2 Delta → Response Correlation

#### **Current Reality:**
- ❌ Validation script does not exist
- ❌ No MMRF cohort data downloaded
- ❌ No validation tests run
- ❌ No validation results documented

#### **Impact:** 🔴 **CRITICAL**
- Cannot validate predictions against real patient data
- Mission success criteria cannot be verified

---

### **5. Data Acquisition** ❌ **0% COMPLETE**

#### **Mission Requirement:**
- File: `scripts/data_acquisition/download_mmrf_commpass.py` (mission line 118-138)
- Target: MMRF CoMMpass (1,154 MM patients, WGS, treatment response)
- Data: mutations, cytogenetics, treatment_response, drug_classes, survival

#### **Current Reality:**
- ❌ No data acquisition script
- ❌ No MMRF cohort downloaded
- ❌ No patient cohort data available
- ⚠️ Validation uses MMRF CoMMpass GDC data (N=219) but not full cohort

#### **Impact:** 🔴 **CRITICAL**
- Cannot run validation tests
- Cannot expand to full mechanism coverage

---

### **6. TRUE SAE Integration** ❌ **0% COMPLETE**

#### **Mission Requirement:**
- Phase 0: TRUE SAE validation (mission lines 649-1274)
- Script: `scripts/sae/extract_sae_incremental.py`
- Script: `scripts/sae/validate_sae_features.py`
- Goal: Determine if TRUE SAE adds value over Proxy SAE

#### **Current Reality:**
- ❌ SAE extraction scripts do not exist
- ❌ No incremental extraction pipeline
- ❌ No SAE validation against outcomes
- ⚠️ Currently using Proxy SAE (gene-level) only

#### **Impact:** 🟡 **HIGH**
- Cannot answer: "Does TRUE SAE add value?"
- Missing competitive advantage (mission differentiator)

---

### **7. Frontend MM Resistance Panel** ❌ **NOT CREATED**

#### **Mission Requirement:**
- File: `components/myeloma/MMResistancePanel.jsx` (mission line 477-554)
- Features:
  - Per-drug-class risk display
  - Mechanism breakdown
  - Alternatives
  - High-risk cytogenetics alerts

#### **Current Reality:**
- ❌ Component does not exist
- ⚠️ Basic MM frontend exists but no resistance panel

#### **Impact:** 🟡 **MEDIUM**
- Users cannot see resistance predictions in UI
- Missing frontend integration

---

### **8. Evo2 Integration** ❌ **NOT INTEGRATED**

#### **Mission Requirement:**
- Evo2 variant scoring for resistance prediction (mission line 461-463)
- Correlation: Evo2 delta vs treatment response (r ≥ 0.3 target)

#### **Current Reality:**
- ✅ Evo2 service exists (`/api/evo/score_variant_multi`)
- ❌ Not integrated into MM resistance prediction
- ❌ No Evo2 → response correlation analysis

#### **Impact:** 🟡 **MEDIUM**
- Missing AI-powered signal (mission differentiator)

---

## 📊 COMPONENT-BY-COMPONENT STATUS

| Component | Mission Requirement | Current Status | Gap | Priority |
|-----------|---------------------|----------------|-----|----------|
| **Backend API** | `/api/mm/resistance/predict` | ✅ Exists (`/api/resistance/predict` with MM routing) | Minor (endpoint name) | 🟢 Low |
| **Resistance Mutations** | PSMB5, CRBN, IKZF1/3, etc. | ❌ Not implemented | **CRITICAL** | 🔴 P0 |
| **Pathway Service** | `mm_pathway_service.py` | ❌ Not created | High | 🟡 P1 |
| **Resistance Service** | `mm_resistance_service.py` | ⚠️ Logic in prophet service | Medium | 🟡 P1 |
| **Validation Scripts** | `validate_mm_resistance.py` | ❌ Not created | **CRITICAL** | 🔴 P0 |
| **Data Acquisition** | MMRF CoMMpass download | ❌ Not done | **CRITICAL** | 🔴 P0 |
| **TRUE SAE** | Incremental extraction | ❌ Not implemented | High | 🟡 P1 |
| **Frontend Panel** | `MMResistancePanel.jsx` | ❌ Not created | Medium | 🟢 P2 |
| **Evo2 Integration** | Evo2 scoring | ❌ Not integrated | Medium | 🟢 P2 |
| **Cytogenetics** | del(17p), t(4;14), 1q | ✅ Implemented (literature) | None | ✅ Done |
| **Treatment Line** | 1L/2L/3L multipliers | ✅ Implemented | None | ✅ Done |
| **Gene Markers** | DIS3, TP53 | ✅ Validated | Missing 8+ genes | 🟡 P1 |

---

## 🔍 DETAILED FINDINGS

### **Finding 1: Basic Infrastructure Exists But Incomplete**

**What Works:**
- ✅ `/api/resistance/predict` endpoint exists and routes MM requests
- ✅ `predict_mm_resistance()` method in `resistance_prophet_service.py`
- ✅ Basic gene-level markers (DIS3, TP53) validated
- ✅ Cytogenetics support (del(17p), t(4;14), 1q gain)
- ✅ Treatment line adjustment logic
- ✅ Next-line recommendations via playbook service

**What's Missing:**
- ❌ Drug-class specific resistance mutations (PSMB5 → PI, CRBN → IMiD)
- ❌ Pathway burden computation
- ❌ Dedicated MM service layer
- ❌ Validation framework

**Verdict:** Foundation is solid (~60%) but missing core mechanism expansion.

---

### **Finding 2: Mission Document vs. Reality Mismatch**

**Mission Claims:**
- "Basic resistance router exists" ✅ **TRUE**
- "PSMB5 mutations (PI) defined" ❌ **FALSE** - Not in code
- "CRBN mutations (IMiDs) defined" ❌ **FALSE** - Not in code
- "MM doctrine exists" ✅ **TRUE** (`.cursor/rules/MM/`)
- "Evo2 integration working" ⚠️ **PARTIAL** - Service exists but not integrated
- "Frontend exists" ✅ **TRUE** - Basic frontend exists

**Reality:**
- Basic router: ✅ Exists
- PSMB5/CRBN: ❌ Not implemented
- Evo2: ⚠️ Service exists, not integrated into MM resistance
- Frontend: ✅ Basic exists, no resistance panel

---

### **Finding 3: Validation Gap (Critical)**

**Mission Requirement:**
- Phase 3: Validation Framework (Week 2-3)
- 5 validation tests against MMRF cohort
- Success criteria: PSMB5→PI RR≥2.0, CRBN→IMiD RR≥2.5, etc.

**Current Reality:**
- ❌ No validation scripts
- ❌ No MMRF cohort downloaded
- ⚠️ DIS3/TP53 validated on MMRF GDC (N=219) but not full cohort
- ❌ No PSMB5/CRBN validation (because mutations not implemented)

**Impact:** Cannot verify mission success criteria.

---

### **Finding 4: TRUE SAE Prerequisite Not Started**

**Mission Requirement:**
- Phase 0: TRUE SAE Validation (Prerequisite)
- Question: "Do SAE features predict outcomes better than Proxy SAE?"
- Method: Incremental extraction (10 → 50 → 150 patients)
- Cost: ~$20-30 Modal

**Current Reality:**
- ❌ No SAE extraction scripts
- ❌ No incremental pipeline
- ❌ No validation analysis
- ⚠️ Currently using Proxy SAE (gene-level) only

**Impact:** Cannot answer core question about SAE value.

---

### **Finding 5: Frontend Integration Incomplete**

**Mission Requirement:**
- `MMResistancePanel.jsx` component
- Per-drug-class risk display
- Mechanism breakdown
- Alternatives display

**Current Reality:**
- ✅ `MyelomaDigitalTwin.jsx` exists
- ✅ `MyelomaResponseDisplay.jsx` exists
- ❌ No `MMResistancePanel.jsx`
- ⚠️ Unclear if resistance API is called from frontend

**Impact:** Users cannot see resistance predictions in UI.

---

## 📋 MISSION CHECKLIST STATUS

### **Phase 1: Data Acquisition (Week 1)** ❌ **0% COMPLETE**

- [ ] Download MMRF CoMMpass or alternative MM cohort
- [ ] Extract mutations, cytogenetics, treatment response
- [ ] Create `data/validation/mm_cohort/` with structured data
- [ ] Document data sources and limitations

**Status:** ❌ **NOT STARTED**

---

### **Phase 2: Resistance Mechanism Expansion (Week 1-2)** ⚠️ **20% COMPLETE**

- [x] Basic resistance router exists ✅
- [x] DIS3, TP53 gene markers validated ✅
- [ ] Expand `RESISTANCE_MUTATIONS` with all MM mechanisms ❌
- [ ] Create `mm_pathway_service.py` ❌
- [ ] Add high-risk cytogenetics logic ✅ (literature-based)
- [ ] Add treatment line context ✅

**Status:** ⚠️ **PARTIAL** - Foundation exists, expansion missing

---

### **Phase 3: Validation Framework (Week 2-3)** ❌ **0% COMPLETE**

- [ ] Create `validate_mm_resistance.py` ❌
- [ ] Run Test 1: PSMB5 → PI ❌ (PSMB5 not implemented)
- [ ] Run Test 2: CRBN → IMiD ❌ (CRBN not implemented)
- [ ] Run Test 3: del(17p) → Universal ❌ (no cohort data)
- [ ] Run Test 4: RAS/MAPK → Line ❌ (no cohort data)
- [ ] Run Test 5: Evo2 → Response ❌ (Evo2 not integrated)
- [ ] Document validation results ❌

**Status:** ❌ **NOT STARTED**

---

### **Phase 4: Production Integration (Week 3-4)** ⚠️ **40% COMPLETE**

- [x] Basic API endpoint exists ✅ (`/api/resistance/predict`)
- [x] Basic prediction logic works ✅ (`predict_mm_resistance()`)
- [ ] Create `mm_resistance_service.py` ⚠️ (logic in prophet service)
- [ ] Create API endpoint `/api/mm/resistance/predict` ⚠️ (exists as `/api/resistance/predict`)
- [ ] Create `MMResistancePanel.jsx` ❌
- [ ] Integrate with existing MyelomaDigitalTwin ⚠️ (unclear)
- [ ] End-to-end test ❌

**Status:** ⚠️ **PARTIAL** - Backend works, frontend missing

---

### **Phase 0: TRUE SAE Validation (Prerequisite)** ❌ **0% COMPLETE**

- [ ] Create `extract_sae_incremental.py` ❌
- [ ] Create `validate_sae_features.py` ❌
- [ ] Run Tier 1: 10 patients ❌
- [ ] Run Tier 2: 50 patients ❌
- [ ] Run Tier 3: 150 patients ❌
- [ ] Answer: SAE_ADDS_VALUE or PROXY_SUFFICIENT ❌

**Status:** ❌ **NOT STARTED**

---

## 🎯 SUCCESS CRITERIA STATUS

| Metric | Target | Current Status | Validation |
|--------|--------|----------------|------------|
| **PSMB5 → PI RR** | ≥ 2.0 | ❌ Cannot test (PSMB5 not implemented) | N/A |
| **CRBN → IMiD RR** | ≥ 2.5 | ❌ Cannot test (CRBN not implemented) | N/A |
| **del(17p) HR** | ≥ 2.0 | ⚠️ Literature HR=2.5 (not validated) | Literature only |
| **Evo2 correlation** | r ≥ 0.3 | ❌ Cannot test (Evo2 not integrated) | N/A |
| **Drug classes covered** | 4/4 | ⚠️ 2/4 (PI, IMiD basics only) | Partial |
| **API response time** | < 2s | ✅ Likely met (not tested) | Unknown |

**Overall:** ❌ **0/6 success criteria met** (cannot test most due to missing implementations)

---

## 🔧 FILES THAT SHOULD EXIST (But Don't)

### **Backend Services:**
1. ❌ `api/services/mm_pathway_service.py` - MM pathway mapping
2. ❌ `api/services/mm_resistance_service.py` - Dedicated MM service (logic exists in prophet service)

### **Scripts:**
3. ❌ `scripts/data_acquisition/download_mmrf_commpass.py` - Data extraction
4. ❌ `scripts/validation/validate_mm_resistance.py` - Validation tests
5. ❌ `scripts/sae/extract_sae_incremental.py` - SAE extraction
6. ❌ `scripts/sae/validate_sae_features.py` - SAE validation

### **Frontend:**
7. ❌ `components/myeloma/MMResistancePanel.jsx` - Resistance UI

### **Data:**
8. ❌ `data/validation/mm_cohort/` - Patient cohort data

### **Documentation:**
9. ❌ `.cursor/MOAT/MM_RESISTANCE_VALIDATION.md` - Validation results

---

## 📊 IMPLEMENTATION GAPS BY PRIORITY

### **P0 - Critical (Blocks Mission Success):**

1. **PSMB5/CRBN Resistance Mutations** ❌
   - **Gap:** No drug-class specific mutation checking
   - **Impact:** Cannot predict PI/IMiD resistance (core mission)
   - **Effort:** 2-3 hours
   - **Files:** Add to `resistance_prophet_service.py` or create `mm_resistance_service.py`

2. **MMRF Cohort Data** ❌
   - **Gap:** No patient cohort for validation
   - **Impact:** Cannot validate predictions
   - **Effort:** 1-2 days (data access + extraction)
   - **Files:** `scripts/data_acquisition/download_mmrf_commpass.py`

3. **Validation Framework** ❌
   - **Gap:** No validation tests
   - **Impact:** Cannot verify success criteria
   - **Effort:** 2-3 days
   - **Files:** `scripts/validation/validate_mm_resistance.py`

---

### **P1 - High Priority (Mission Features):**

4. **MM Pathway Service** ❌
   - **Gap:** No pathway burden computation
   - **Impact:** Missing mechanism-level prediction
   - **Effort:** 1 day
   - **Files:** `api/services/mm_pathway_service.py`

5. **Expanded Gene Markers** ⚠️
   - **Gap:** Only 2 genes validated, mission calls for 10+
   - **Impact:** Limited coverage
   - **Effort:** 1-2 days (data + validation)
   - **Files:** Update `MM_HIGH_RISK_GENES` in `resistance_prophet_service.py`

6. **TRUE SAE Validation** ❌
   - **Gap:** Prerequisite not started
   - **Impact:** Cannot answer SAE value question
   - **Effort:** 2-3 hours extraction + analysis
   - **Files:** `scripts/sae/extract_sae_incremental.py`, `validate_sae_features.py`

---

### **P2 - Medium Priority (Enhancement):**

7. **Frontend Resistance Panel** ❌
   - **Gap:** No dedicated UI component
   - **Impact:** Users cannot see predictions
   - **Effort:** 1-2 days
   - **Files:** `components/myeloma/MMResistancePanel.jsx`

8. **Evo2 Integration** ❌
   - **Gap:** Evo2 not integrated into MM resistance
   - **Impact:** Missing AI signal
   - **Effort:** 1 day
   - **Files:** Update `predict_mm_resistance()` to call Evo2 service

9. **Dedicated MM Service** ⚠️
   - **Gap:** Logic in prophet service, not dedicated service
   - **Impact:** Architecture mismatch with mission
   - **Effort:** 0.5 day (refactor)
   - **Files:** Create `api/services/mm_resistance_service.py`

---

## 🚨 CRITICAL BLOCKERS

### **Blocker 1: Missing Core Resistance Mutations**

**Issue:** Mission document specifies PSMB5/CRBN mutations as priority #1, but they are not implemented.

**Evidence:**
- Mission line 146-280: Comprehensive `MM_RESISTANCE_MUTATIONS` dictionary
- Current code: Only DIS3/TP53 checked (gene-level, not drug-class specific)
- No PSMB5 mutation checking in `resistance_prophet_service.py`

**Impact:** 🔴 **CRITICAL** - Core mission functionality missing

**Fix Required:**
1. Add `MM_RESISTANCE_MUTATIONS` dictionary to `resistance_prophet_service.py`
2. Add mutation checking logic in `_detect_mm_high_risk_genes()` or new method
3. Integrate with drug_class parameter

---

### **Blocker 2: No Validation Data**

**Issue:** Cannot validate predictions without MMRF cohort data.

**Evidence:**
- Mission Phase 1: Data acquisition (Week 1) - **NOT STARTED**
- Mission Phase 3: Validation framework - **BLOCKED** (no data)
- Current: Only DIS3/TP53 validated on MMRF GDC subset (N=219)

**Impact:** 🔴 **CRITICAL** - Cannot verify mission success criteria

**Fix Required:**
1. Download MMRF CoMMpass data (or use cBioPortal MM as fallback)
2. Extract mutations, cytogenetics, treatment response
3. Create structured cohort file

---

### **Blocker 3: TRUE SAE Prerequisite Not Started**

**Issue:** Mission Phase 0 (prerequisite) not completed.

**Evidence:**
- Mission lines 649-1274: Comprehensive TRUE SAE validation plan
- Current: Using Proxy SAE (gene-level) only
- Question unanswered: "Does TRUE SAE add value?"

**Impact:** 🟡 **HIGH** - Missing competitive advantage

**Fix Required:**
1. Create `extract_sae_incremental.py` script
2. Run Tier 1 (10 patients) → Tier 2 (50) → Tier 3 (150)
3. Run `validate_sae_features.py` analysis
4. Answer: SAE_ADDS_VALUE or PROXY_SUFFICIENT

---

## 📈 PROGRESS METRICS

### **By Phase:**

| Phase | Planned | Actual | Completion |
|-------|---------|--------|------------|
| **Phase 0: TRUE SAE** | Prerequisite | ❌ Not started | 0% |
| **Phase 1: Data Acquisition** | Week 1 | ❌ Not started | 0% |
| **Phase 2: Mechanism Expansion** | Week 1-2 | ⚠️ Partial | 20% |
| **Phase 3: Validation** | Week 2-3 | ❌ Not started | 0% |
| **Phase 4: Production** | Week 3-4 | ⚠️ Partial | 40% |

### **By Component:**

| Component | Status | Notes |
|-----------|--------|-------|
| **Backend API** | ✅ 60% | Basic endpoint works, missing mechanisms |
| **Resistance Mutations** | ❌ 0% | Only DIS3/TP53, missing PSMB5/CRBN |
| **Pathway Service** | ❌ 0% | Not created |
| **Validation** | ❌ 0% | No scripts, no data |
| **Frontend** | ⚠️ 20% | Basic exists, no resistance panel |
| **TRUE SAE** | ❌ 0% | Prerequisite not started |

---

## 🎯 RECOMMENDATIONS

### **Immediate Actions (P0 - This Week):**

1. **Add PSMB5/CRBN Resistance Mutations** (2-3 hours)
   - Create `MM_RESISTANCE_MUTATIONS` dictionary in `resistance_prophet_service.py`
   - Add mutation checking logic for PSMB5 → PI, CRBN → IMiD
   - Test with known resistance cases

2. **Download MMRF Cohort Data** (1-2 days)
   - Use cBioPortal MM API as fallback if MMRF access delayed
   - Extract mutations, cytogenetics, treatment response
   - Create structured cohort file

3. **Create Validation Script** (1 day)
   - Create `scripts/validation/validate_mm_resistance.py`
   - Implement 5 validation tests
   - Run against cohort data

### **Short-Term (P1 - Next 2 Weeks):**

4. **Create MM Pathway Service** (1 day)
   - Create `api/services/mm_pathway_service.py`
   - Implement `compute_mm_pathway_burden()`
   - Integrate into resistance prediction

5. **TRUE SAE Validation** (2-3 hours + Modal cost)
   - Create extraction scripts
   - Run incremental pipeline (10 → 50 → 150 patients)
   - Answer SAE value question

6. **Expand Gene Markers** (1-2 days)
   - Add IKZF1/3, CUL4A, DDB1 to validated markers
   - Validate against MMRF cohort
   - Update `MM_HIGH_RISK_GENES`

### **Medium-Term (P2 - Next Month):**

7. **Frontend Integration** (1-2 days)
   - Create `MMResistancePanel.jsx`
   - Integrate with resistance API
   - Add to MyelomaDigitalTwin

8. **Evo2 Integration** (1 day)
   - Add Evo2 scoring to `predict_mm_resistance()`
   - Correlate delta scores with response
   - Use as secondary signal

---

## 📝 CONCLUSION

**Current State:** The MM Resistance Prediction mission has a **solid foundation (~40% complete)** with working backend API and basic gene-level markers, but is **missing critical components**:

1. ❌ **Core resistance mutations** (PSMB5, CRBN) - **BLOCKER**
2. ❌ **Validation framework** - **BLOCKER**
3. ❌ **MMRF cohort data** - **BLOCKER**
4. ❌ **TRUE SAE validation** - **PREREQUISITE NOT STARTED**
5. ⚠️ **Pathway service** - Missing
6. ⚠️ **Frontend panel** - Missing

**Recommendation:** Focus on **P0 blockers first** (PSMB5/CRBN mutations, MMRF data, validation) before proceeding with enhancements. The foundation is good, but core mission functionality is incomplete.

**Estimated Time to Complete Mission:** 3-4 weeks (as originally planned) if starting from current state.

---

**Last Updated:** January 28, 2025  
**Next Review:** After P0 blockers addressed

